NCTR 2002-2003 Research Plans – Neurotoxicology Title: Effects of Ibogaine on Neurotransmitter Systems, Generation of Free Radicals and Nitric Oxide Synthase Activity: Correlation with Neurohistological Evaluations in Mouse and Rat Brain Determine the effects of ibogaine on dopamine, serotonin and their metabolite concentrations in different regions of mouse and rat…
Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…
18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…
Although Sacrament of Transition uses ibogaine for spiritual initiation ceremonies; we recognize that the vast majority of individuals who are seeking access to Tabernanthe iboga, do so for the plethora of beneficial effects this sacred plant can offer seekers who are physically dependent upon addictive drugs such as heroin, crack…
International Harm Reduction Conference in Barcelona Ibogaine — Users’ Choice Session Ibogaine Session: Monday, May 12, 2008, at 6:00 PM (18:00) Presenters / Participants Moderator: Alan Clear / Executive Director, Harm Reduction Coalition, NY (USA) Howard S. Lotsof / President, Dora Weiner Foundation, Staten Island, NY (USA) Ibogaine Treatment For…
Hallucinogen May Cure Drug Addiction (Copyright 2004, KRON 4. All rights reserved.) BAY AREA (KRON) — Drug addiction has been the plague of modern America. But that could now change forever. What started as a rumor may now actually be an incredible breakthrough in the battle against addictions of all…
by James Kent An interview with Eric Taub James Kent is Publisher of Trip / Copyright © 2005, Tripzine.com For nine years Eric Taub has been finding creative ways to treat patients and addicts with a powerful psychedelic substance known as ibogaine. Originally found in the West-African shrub Tanernanthe iboga,…
University of Miami’s Deborah Mash believes ibogaine could be the wonder drug to end all drugs. And she’s ready to risk everything to prove it. By Paula Park (Originally published in Miami New Times — 09.11.1997) Deborah Mash and her three colleagues from the University of Miami strolled into the…
Sections of interview taken from: Voices of Truth Conversations with Scientists, Thinkers and Healers by Nina L. Diamond Journalist and writer Nina L. Diamond brings a rare insight and wit to the longest, most in-depth conversations ever published with fourteen prominent and innovate scientists, thinkers and healers, including best-selling authors…
An Array of New Drugs Show Promise in Fighting Addiction by: Gautam Naik The Wall Street Journal — (July 15, 2002) Could people be inoculated against drug addictions the way they can against some infectious diseases? It may be possible. Despite disappointing past efforts to treat addictions with medicine, recent…